|
Index of reports
> Cases resulting in death (64)
> Cases with Toxic Epidermal Necrolysis (8)
Below is the selection of adverse event reports related to Aranesp (Erythropoiesis Stimulating Protein) that includes cases resulting in death where reactions include toxic epidermal necrolysis.
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from France on 2007-05-14
Patient: 71 year old female
Adverse reactions / side effects: Eczema, Pyrexia, Urticaria Generalised, Pruritus Generalised, Nephritic Syndrome, Thrombocytopenia, Escherichia Sepsis, Renal Failure Acute, Angioedema, Anaemia, General Physical Health Deterioration, Toxic Epidermal Necrolysis, Drug Rash With Eosinophilia and Systemic Symptoms, Staphylococcal Infection, Dehydration, Inflammation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Aranesp
Indication: Anaemia of Malignant Disease
Oflocet
Administration route: Oral
Start date: 2006-10-04
End date: 2006-10-14
Neurontin
Administration route: Oral
Start date: 2006-11-01
End date: 2006-11-02
Nexium
Administration route: Oral
Start date: 2006-10-07
End date: 2006-10-11
Sintrom
Administration route: Oral
Start date: 2006-10-31
End date: 2006-11-02
Levothyroxine Sodium
End date: 2006-11-02
Inipomp
End date: 2006-09-08
Other drugs received by patient: Eprex; Lasix; Bactrim; Cozaar; Orgametril; Gaviscon; Simvastatin; Valacyclovir Hydrochloride
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from France on 2007-05-04
Patient: 71 year old female
Adverse reactions / side effects: Angioedema, Anaemia, Toxic Epidermal Necrolysis, General Physical Health Deterioration, Eczema, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Urticaria Generalised, Pruritus Generalised, Renal Failure, Nephritic Syndrome, Staphylococcal Infection, Dehydration, Thrombocytopenia, Escherichia Sepsis, Inflammation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Aranesp
Indication: Anaemia of Malignant Disease
Eprex
Start date: 2006-08-04
End date: 2006-08-16
Oflocet
Administration route: Oral
Start date: 2006-10-04
End date: 2006-10-14
Neurontin
Administration route: Oral
Start date: 2006-11-01
End date: 2006-11-02
Nexium
Administration route: Oral
Start date: 2006-10-07
End date: 2006-10-11
Lasix
Administration route: Oral
Start date: 2006-09-15
End date: 2006-10-13
Sintrom Mitis
Administration route: Oral
Start date: 2006-10-31
End date: 2006-11-02
Levothyroxine Sodium
End date: 2006-11-02
Other drugs received by patient: Bactrim; Cozaar; Inipomp; Orgametril; Gaviscon; Simvastatin; Valacyclovir Hydrochloride
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-12
Patient: 71 year old female
Adverse reactions / side effects: Toxic Epidermal Necrolysis, Drug Rash With Eosinophilia and Systemic Symptoms
Adverse event resulted in: death
Suspect drug(s):
Oflocet
Administration route: Oral
Indication: Sepsis
Start date: 2006-10-04
End date: 2006-10-14
Aranesp
Indication: Anaemia
Nexium
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Minisintrom
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Neurontin
Administration route: Oral
Indication: Neuropathy Peripheral
Other drugs received by patient: Lasix; Cozaar; Fludarabin Phosphate; Levothyroxine Sodium; Bactrim; Lodales; Valacyclovir HCL; Inipomp; Orgametril; Gaviscon; Cyclophosphamide NOS; Cefotaxime; Amikacin; Gentamicin
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a individual with unspecified qualification from France on 2007-04-09
Patient: 71 year old female
Adverse reactions / side effects: Toxic Epidermal Necrolysis, Drug Rash With Eosinophilia and Systemic Symptoms
Adverse event resulted in: death
Suspect drug(s):
Oflocet / 00731801 /
Administration route: Oral
Start date: 2006-10-04
End date: 2006-10-14
Lasilix / 00032601 /
Administration route: Oral
Start date: 2006-09-15
End date: 2006-10-13
Neurontin
Administration route: Oral
End date: 2006-11-01
Aranesp
Nexium
Administration route: Oral
Start date: 2006-10-07
End date: 2006-10-11
Minisintrom
Administration route: Oral
End date: 2006-10-31
Other drugs received by patient: Levothyroxine Sodium; Bactrim; Lodales; Cozaar; Valacyclovir HCL; Inipomp / 01263201 /; Orgametril; Gaviscon / 01405501 /
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-06
Patient: 71 year old female
Adverse reactions / side effects: Pyrexia, Eczema, Urticaria Generalised, Pruritus Generalised, Nephritic Syndrome, Thrombocytopenia, Angioedema, Anaemia, Toxic Epidermal Necrolysis, General Physical Health Deterioration, Eosinophilia, Renal Failure, Staphylococcal Infection, Dehydration, Sepsis, Inflammation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Aranesp
Indication: Anaemia of Malignant Disease
Eprex
Start date: 2006-08-04
End date: 2006-08-16
Oflocet
Administration route: Oral
Start date: 2006-10-04
End date: 2006-10-14
Neurontin
Administration route: Oral
Start date: 2006-11-01
End date: 2006-11-02
Nexium
Administration route: Oral
Start date: 2006-10-07
End date: 2006-10-11
Lasix
Administration route: Oral
Start date: 2006-09-15
End date: 2006-10-13
Sintrom Mitis
Administration route: Oral
Start date: 2006-10-31
End date: 2006-11-02
Other drugs received by patient: Bactrim; Levothyroxine Sodium; Cozaar; Inipomp; Orgametril; Gaviscon; Simvastatin; Valacyclovir Hydrochloride
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a individual with unspecified qualification from France on 2007-04-06
Patient: 71 year old female
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: death
Suspect drug(s):
Oflocet / 00731801 /
Administration route: Oral
Start date: 2006-10-04
End date: 2006-10-14
Lasilix / 00032601 /
Administration route: Oral
Start date: 2006-09-15
End date: 2006-10-13
Neurontin
Administration route: Oral
End date: 2006-11-01
Aranesp
Nexium
Administration route: Oral
Start date: 2006-10-07
End date: 2006-10-11
Minisintrom
Administration route: Oral
End date: 2006-10-31
Other drugs received by patient: Levothyroxine Sodium; Bactrim; Lodales; Cozaar; Valacyclovir HCL; Inipomp / 01263201 /; Orgametril; Gaviscon / 01405501 /
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a individual with unspecified qualification on 2007-04-02
Patient: 71 year old female
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: death
Suspect drug(s):
Oflocet / 00731801 /
Administration route: Oral
Start date: 2006-10-04
End date: 2006-10-14
Lasilix / 00032601 /
Administration route: Oral
Start date: 2006-09-15
End date: 2006-10-13
Neurontin
Administration route: Oral
End date: 2006-11-01
Aranesp
Nexium
Administration route: Oral
Start date: 2006-10-07
End date: 2006-10-11
Minisintrom
Administration route: Oral
End date: 2006-10-31
Other drugs received by patient: Levothyroxine Sodium; Bactrim; Lodales; Cozaar; Valacyclovir HCL; Inipomp / 01263201 /; Orgametril; Gaviscon / 01405501 /
Adverse event in 71 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from France on 2007-03-30
Patient: 71 year old female
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Nexium
Administration route: Oral
Start date: 2006-10-07
End date: 2006-10-11
Oflocet
Administration route: Oral
Indication: Escherichia Sepsis
Start date: 2006-10-04
End date: 2006-10-14
Neurontin
Administration route: Oral
Indication: Autonomic Neuropathy
End date: 2006-11-01
Aranesp
Indication: Anaemia
Lasix
Administration route: Oral
Indication: Cardiac Failure
Start date: 2006-09-15
End date: 2006-10-13
Minisintrom
End date: 2006-10-31
Levothyroxine Sodium
End date: 2006-11-01
Other drugs received by patient: Fludara; Endoxan; Eprex; Bactrim; Lodales; Cozaar; Valacyclovir HCL; Inipomp; Orgametril; Gaviscon; Claforan; Amiklin; Gentamicin; Antihistamines; Local Corticosteroid; Galien's Cerate
|
